Evidence map›Paper›PMID 42620254›Full record

ArticleFrontiers in immunology2026

Germline based SARS-CoV-2 specific B cell repertoire motif identified with novel sequence based bioinformatic pipeline.

Daniel Fridman, Lena Israitel, Areen Shtewe, Uri Hershberg

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Daniel FridmanHuman Biology Section, School of Life Sciences, Faculty of Science, University of Haifa, Haifa, Israel.
Lena IsraitelHuman Biology Section, School of Life Sciences, Faculty of Science, University of Haifa, Haifa, Israel.
Areen ShteweHuman Biology Section, School of Life Sciences, Faculty of Science, University of Haifa, Haifa, Israel.
Uri HershbergHuman Biology Section, School of Life Sciences, Faculty of Science, University of Haifa, Haifa, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human antibody diversification, achieved through gene selection and somatic hypermutation (SHM), is critical for protecting against diverse pathogens. This study investigates whether specific immune responses possess distinct receptor sequence patterns that differentiate them from the general immune repertoire. Utilizing data from an anti-SARS-CoV-2 vaccination study, we analyzed two properties of SARS-CoV-2 specific memory B-cells and compared them to the background immune repertoire. Driven by somatic hypermutation (SHM), B cells exhibit a highly dynamic nature. Consequently, groups sharing a direct lineage from a common progenitor are defined as B-cell clones. First, we studied substitution survival - the number of clones to survive amino acid substitutions across the variable region of the B cell receptor (BCR). Second, we analyzed clonal amino acid trimer usage patterns across the BCR gene to gain insight into prevalent genomic motifs found in different immune sub-repertoires. We demonstrated that these two metrics can effectively cluster and distinguish SARS-CoV-2 specific B cell responses. Furthermore, we observed that SARS-CoV-2-specific B-cells show an increased tendency to utilize and conserve a specific CDR2 motif derived from the VH3-30 gene and its alleles. Beyond identifying a specific germline motif related to SARS-CoV-2-specific B-cells response, our findings demonstrate that our novel analysis pipeline can successfully identify signatures of specific immune responses. We therefore suggest that using the methods described here could be key for the study of the substrate of B-cell selection and protective immunity in other vaccine and pathogen responses.

Indexed as

B-LymphocytesCOVID-19Memory B CellsReceptors, Antigen, B-CellSARS-CoV-2Amino Acid MotifsAntibodies, ViralComputational BiologyCOVID-19 VaccinesHumansImmunoinformaticsSomatic Hypermutation, ImmunoglobulinAntibodies, ViralCOVID-19 VaccinesReceptors, Antigen, B-Cellantigen responsecomputational biologyCOVID 19immune repertoireLPAselectionsequence motif

Identifiers

PMID42620254
PMCPMC13485583

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.